Cost-effectiveness of intravenous 5 mg zoledronic acid to prevent subsequent clinical fractures in postmenopausal women after hip fracture: a model-based analysis
Standard
Cost-effectiveness of intravenous 5 mg zoledronic acid to prevent subsequent clinical fractures in postmenopausal women after hip fracture: a model-based analysis. / Bleibler, Florian; König, Hans-Helmut.
in: HCHE Research Paper, Jahrgang 10, 2016, S. 1-37.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung
Harvard
Bleibler, F & König, H-H 2016, 'Cost-effectiveness of intravenous 5 mg zoledronic acid to prevent subsequent clinical fractures in postmenopausal women after hip fracture: a model-based analysis', HCHE Research Paper, Jg. 10, S. 1-37.
APA
Bleibler, F., & König, H-H. (2016). Cost-effectiveness of intravenous 5 mg zoledronic acid to prevent subsequent clinical fractures in postmenopausal women after hip fracture: a model-based analysis. HCHE Research Paper, 10, 1-37.
Vancouver
Bleibler F, König H-H. Cost-effectiveness of intravenous 5 mg zoledronic acid to prevent subsequent clinical fractures in postmenopausal women after hip fracture: a model-based analysis. HCHE Research Paper. 2016;10:1-37.
Bibtex
@article{0cb4ba74bed04f8ba9da856a88e1ad26,
title = "Cost-effectiveness of intravenous 5 mg zoledronic acid to prevent subsequent clinical fractures in postmenopausal women after hip fracture: a model-based analysis",
author = "Florian Bleibler and Hans-Helmut K{\"o}nig",
year = "2016",
language = "English",
volume = "10",
pages = "1--37",
journal = "HCHE Research Paper",
issn = "2191-6233",
}
RIS
TY - JOUR
T1 - Cost-effectiveness of intravenous 5 mg zoledronic acid to prevent subsequent clinical fractures in postmenopausal women after hip fracture: a model-based analysis
AU - Bleibler, Florian
AU - König, Hans-Helmut
PY - 2016
Y1 - 2016
M3 - SCORING: Journal article
VL - 10
SP - 1
EP - 37
JO - HCHE Research Paper
JF - HCHE Research Paper
SN - 2191-6233
ER -
